Overview
Ying-ying Xu practices practicing medicine in Hangzhou, China.
Their clinical expertise encompasses Nasal Polyps, Allergic Rhinitis, Sinusitis, and Laryngeal Cancer.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ying-ying Xu
Is Ying-ying Xu a top-rated expert for Nasal Polyps?
MediFind is an objective health platform that identifies experts based on real-world data. Ying-ying Xu is classified as an Experienced expert for Nasal Polyps, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ying-ying Xu participate in research or clinical trials?
Yes. Ying-ying Xu has published 8 articles and abstracts on conditions like Nasal Polyps. You can view a list of Ying-ying Xu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Allergic RhinitisXu isExperienced. Learn about Allergic Rhinitis.
- Laryngeal CancerXu isExperienced. Learn about Laryngeal Cancer.
- Nasal PolypsXu isExperienced. Learn about Nasal Polyps.
- SinusitisXu isExperienced. Learn about Sinusitis.
- Throat CancerXu isExperienced. Learn about Throat Cancer.